Early Linvoseltamab Use Prevents Myeloma Progression: Paula Rodríguez-Otero, MD, PhD
The LINKER-SMM1 trial evaluates linvoseltamab's safety and efficacy in high-risk smoldering multiple myeloma, aiming to delay disease progression.
